Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.

Soltero L, Carbajal H, Xu J, McCarthy J, Suki WN, Gaber AO, Adrogué HE.

Clin Transplant. 2012 Mar-Apr;26(2):300-4. doi: 10.1111/j.1399-0012.2011.01539.x. Epub 2011 Nov 2.

PMID:
22044717
2.

Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.

Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.

Am J Nephrol. 2012;35(4):365-71. doi: 10.1159/000337482. Epub 2012 Apr 2.

PMID:
22473253
3.

Monoclonal gammopathy of undetermined significance does not affect outcomes in patients undergoing solid organ transplants.

Jimenez-Zepeda VH, Heilman RL, Engel RA, Carey EJ, Freeman C, Rakela J, Mulligan DC, Fonseca R, Stewart AK.

Transplantation. 2011 Sep 15;92(5):570-4. doi: 10.1097/TP.0b013e318225db2c.

PMID:
21712755
4.

[Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].

Stelmach-Gołdyś A, Czarkowska-Paczek B.

Przegl Lek. 2012;69(5):194-6. Review. Polish.

PMID:
23050415
5.

Follow-up monoclonal gammopathy of undetermined significance in kidney transplant.

Cuéllar-García C, Sevillano Ruiz-Mateos C, Mazuecos Blanca MA, Narvaez Mejia C, Fernandez Valle MC, Martin Reina V, Gonzalez Bernal M, Yera Cobo M, Rodriguez Lopez R, de Cos Hohr C, Garrastazul MP, Marchante I, Paz Coll A, Capote Huelva FJ.

Transplant Proc. 2015 Jan-Feb;47(1):78-80. doi: 10.1016/j.transproceed.2014.11.021.

PMID:
25645776
6.

[Monoclonal gammopathy of undetermined significance (MGUS) in Mexican mestizos: one institution's experience].

Ruiz-Delgado GJ, Gómez Rangel JD.

Gac Med Mex. 2004 Jul-Aug;140(4):375-9. Spanish.

PMID:
15456147
7.

[Monoclonal gammopathy of undetermined significance].

Chaïbi P, Merlin L, Thomas C, Piette F.

Ann Med Interne (Paris). 2002 Nov;153(7):459-66. Review. French.

PMID:
12598832
8.

The relationship between monoclonal gammopathy of undetermined significance and venous thromboembolic disease.

Cohen AL, Sarid R.

Thromb Res. 2010 Mar;125(3):216-9. doi: 10.1016/j.thromres.2009.01.004. Epub 2009 Feb 3.

PMID:
19193398
9.

Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.

Rostaing L, Modesto A, Abbal M, Durand D.

Am J Nephrol. 1994;14(3):187-91.

PMID:
7977478
10.

Monoclonal gammopathy of undetermined significance (MGUS).

Kyle RA.

Baillieres Clin Haematol. 1995 Dec;8(4):761-81. Review.

PMID:
8845571
11.

Outcomes of Monoclonal Gammopathy of Undetermined Significance in Patients Who Underwent Kidney Transplantation.

Bancu I, Cañas L, Juega FJ, Pérez M, Malumbres S, Bonet J, Lauzurica R.

Transplant Proc. 2015 Oct;47(8):2344-5. doi: 10.1016/j.transproceed.2015.08.023.

PMID:
26518922
12.

Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.

Anagnostopoulos A, Evangelopoulou A, Sotou D, Gika D, Mitsibounas D, Dimopoulos MA.

Ann Hematol. 2002 Jul;81(7):357-61. Epub 2002 Jul 11.

PMID:
12185503
13.

Patterns of monoclonal immunoglobulins and serum free light chains are significantly different in black compared to white monoclonal gammopathy of undetermined significance (MGUS) patients.

Weiss BM, Minter A, Abadie J, Howard R, Ascencao J, Schechter GP, Kuehl M, Landgren O.

Am J Hematol. 2011 Jun;86(6):475-8. doi: 10.1002/ajh.22025. Epub 2011 May 4.

14.

Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.

Leung N, Bridoux F, Hutchison CA, Nasr SH, Cockwell P, Fermand JP, Dispenzieri A, Song KW, Kyle RA; International Kidney and Monoclonal Gammopathy Research Group.

Blood. 2012 Nov 22;120(22):4292-5. doi: 10.1182/blood-2012-07-445304. Epub 2012 Oct 9. Review.

15.

Monoclonal Gammopathy of Undetermined Significance after Kidney Transplantation: single-center experience.

Alfano G, Fontana F, Colaci E, Messerotti A, Bettelli F, Potenza L, Luppi M, Cappelli G.

Transplantation. 2017 Jul 21. doi: 10.1097/TP.0000000000001884. [Epub ahead of print]

PMID:
28731904
16.

Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myeloma.

Wadhera RK, Kyle RA, Larson DR, Dispenzieri A, Kumar S, Lazarus HM, Rajkumar SV.

Blood. 2011 Sep 15;118(11):2985-7. doi: 10.1182/blood-2011-04-349175. Epub 2011 Jul 15.

17.

Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance.

Goebel TE, Schiltz NK, Woodside KJ, Pillai AC, Caimi PF, Lazarus HM, Koroukian SM, Campagnaro EL.

Clin Transplant. 2015 Sep;29(9):851-7. doi: 10.1111/ctr.12595. Epub 2015 Aug 20.

18.

Monoclonal gammopathy of undeterminated significance: introduction and current clinical issues.

Klincová M, Sandecká V, Mikuláiová A, Radocha J, Maisnar V, Hájek R.

Klin Onkol. 2011;24 Suppl:S14-7. Review.

PMID:
21923058
19.

[Benign monoclonal gammopathy].

Shirota T, Kondo M, Uchida H, Ito H.

Nihon Rinsho. 1995 Mar;53(3):720-4. Review. Japanese.

PMID:
7699912
20.

The relationship between hypogammaglobulinemia, monoclonal gammopathy of undetermined significance and humoral immunodeficiency: a case series.

Zemble RM, Takach PA, Levinson AI.

J Clin Immunol. 2011 Oct;31(5):737-43. doi: 10.1007/s10875-011-9548-0. Epub 2011 Jun 5.

PMID:
21643891

Supplemental Content

Support Center